Biosensor for the Detection of Antibodies and Small Molecules

A novel platform technology for point-of-care non-invasive tests.
Tech ID #: 872.5
IP status: US composition of matter patent granted January 2022.
Prototype available: proof of principle has been validated on various clinical samples.
Inexpensive and easy to use: no sample purification and processing needed.
Fast: test results available from 10 minutes to one hour, depending on the target.

BACKGROUND 

Researchers at the University of Calgary have created a point-of-care (POC) biosensor platform for any small molecule or biological samples. This biosensor relies on cognate enzyme complementation and produces glucose as a final product. The resultant glucose can be easily measured using common or custom-build glucometers. This new method provides a way to detect a wide range of analytes in various biological samples, including blood and colostrum, with a high degree of specificity and sensitivity.

 

AREAS OF APPLICATION

Verified in clinical samples:

  • Small molecule detection – bovine serum calcium test for hypocalcaemia diagnosis1.
  • Antibody detection – sera antibody test against bovine leukemia virus (BLV)2,3.
  • Immunoglobulin detection:
    • Serum IgG concentration test in various animal species4.
    • Colostrum IgG concentration test5.
  • Genetic targets, after amplicons by PCR or isothermal amplification (LAMP)6.
  • Protein aggregation detection3.

 

COMPETITIVE ADVANTAGES

  • High sensitivity and specificity demonstrated on various clinical samples.
  • Portable, inexpensive, and simple to use – direct use on biological samples, no purification or processing needed.
  • Fast – test results can be available within 10 minutes.
  • The inventor has access to large animal resources for clinical trials.

 

PUBLICATIONS AND RESOURCES

Announcements

Events
02 Oct 2023

Social Innovator Breakfast Club – October 2

News

UCalgary’s new Aerospace Innovation Hub soars to new heights with $2.5 million funding

News

Light might be the answer to our data security issues, quantum researcher says

Questions? Need more information?

Reach out and connect. Our tech transfer team is ready to help.

Contact Us